Kyle Amber to Private Sector
This is a "connection" page, showing publications Kyle Amber has written about Private Sector.
Connection Strength
0.501
-
Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8.
Score: 0.501